Related Experiment Videos
Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study
Seminars in Arthritis and Rheumatism
|November 1, 1986
Summary
Immune complex nephropathy is common in patients with mixed connective tissue disease (MCTD), often causing significant kidney issues and complications like hypertension. Corticosteroid therapy can help manage these renal manifestations.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Mixed connective tissue disease (MCTD) is a systemic autoimmune disorder with diverse clinical manifestations.
- Renal involvement, particularly immune complex nephropathy, can be a serious complication of MCTD.
Purpose of the Study:
- To investigate the incidence, clinical features, and outcomes of immune complex nephropathy in patients with MCTD.
- To assess the impact of corticosteroid therapy on renal disease in MCTD patients.
Main Methods:
- Retrospective analysis of 30 patients with MCTD followed for a mean of 10 years.
- Detailed review of renal biopsy findings, clinical course, treatment, and patient outcomes.
Main Results:
- Eleven of 30 patients developed immune complex nephropathy, with various histological types (membranous, mesangial, mixed, sclerosing).
- Nephrotic syndrome (NS) occurred in nine of these 11 patients. Patients with renal disease had more systemic symptoms.
- Corticosteroid therapy led to resolution or improvement in 72% of nephropathy and 62% of NS episodes. Complications included hypertension, chronic renal failure, and sepsis.
Conclusions:
- Immune complex nephropathy is a significant and relatively common complication in MCTD, associated with considerable morbidity.
- Early diagnosis and management, including corticosteroid therapy, are crucial for improving outcomes and preventing progression to end-stage renal disease.